StockData
Immuron Ltd logo

Immuron Ltd (IMRN) income statement

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.00 (-0.52%)

Close on Nov 18, 2026Market cap $6.99MP/E –Yield –

Immuron Ltd income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin
64.5%
Operating margin
-49.9%
Net margin
-47.7%
Return on equity, FY2026
–

Financial strength

Current ratio
7.26
Debt to equity
–
Debt to assets
–
Cash to current liabilities
505.1%

Valuation

P/E ratio
–
Price to sales
1.34
Price to book
–
Dividend yield
–

See a number that looks wrong?